Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
Background: Sarcopenia is a geriatric syndrome that is characterized by the gradual muscle loss and frailty in the elderly. Meanwhile, the prevalence of prostate cancer is on the rise worldwide. Mainstay treatments for metastatic prostate cancer are androgen-deprivation therapy and taxane-based chem...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-03-01
|
| Series: | Prostate International |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888217301514 |